Table 2.
Multivariate Cox proportional hazards model analysis of factors associated with progression-free survival
| HR | 95% CI | P-value | |
|---|---|---|---|
| Sex (Male) | 1.20 | 0.71–2.03 | 0.498 |
| Age (≥ 75) | 1.19 | 0.81–1.77 | 0.375 |
| PS (≥ 2) | 0.98 | 0.52–1.72 | 0.946 |
| Smoking (Yes) | 1.12 | 0.67–1.83 | 0.671 |
| EGFR (L858R) | 1.59 | 1.08–2.35 | 0.019* |
| Brain metastasis | 1.48 | 0.96–2.23 | 0.076** |
| Pleural effusion | 1.29 | 0.87–1.91 | 0.198 |
| Liver metastasis | 1.88 | 0.97–3.42 | 0.061** |
| Bone metastasis | 1.45 | 0.95–2.17 | 0.081** |
*P < 0.05, **P < 0.10
HR, hazard ratio; CI, confidence interval; PS, performance status; EGFR, epidermal growth factor receptor